Come up with a name for your new list and we'll add to it:
viDA Therapeutics raised a round of funding on April 25, 2013. Investors include
BDC Venture Capital.
viDA Therapeutics is a platform-based, biotechnology company that is developing first in class therapeutics, across a broad range of diseases, that capitalize on its recent discovery of a new mechanis…